Dr. Matthew David Cheney, MD, PhD

Dr. Cheney practices at MaineHealth Maine Medical Center in Portland, Maine, part of MaineHealth.

Dr. Cheney's NPI, 1326363714, was assigned on March 29, 2010. Dr. Cheney holds Maine license MD20455.

Dr. Cheney's primary practice is MaineHealth Maine Medical Center, at 22 Bramhall St, Portland, ME 04102 in Cumberland County. The practice phone is (207) 662-0111.

Dr. Cheney's primary practice is MaineHealth Maine Medical Center in Portland, Maine, part of MaineHealth. Dr. Cheney is also affiliated with MaineHealth Mid Coast Hospital. The medical group on file is MaineHealth Primary Care - Family Medicine - Portland. Dmand AI also links Dr. Cheney to 2 more hospitals and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cheney practices, 4 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Cheney's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Cheney is licensed in Maine.

CMS data shows 1,674 Medicare services from Dr. Cheney across 16 procedure codes in 2024, for 253 Medicare patients. Medicare paid $102,513 for them.

CMS counts 253 Medicare patients who saw Dr. Cheney in 2024. The largest group is 65 to 74, with 112 patients. 75% of them have cancer, and 70% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.50, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Cheney's median patient age at 72, with 41% women.

In 2024, Dr. Cheney wrote 133 Medicare Part D claims for 68 patients. 89% of them were for generic drugs. CMS names the drug for 59 of them, across 1 drug with 11 or more claims each, at $303 in total drug cost. In 2023, CMS named 45 claims across 1 drug.

Dr. Cheney accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 5 papers to Dr. Cheney, published from 2013 to 2015. 2013 was the busiest year, with 2. The most frequent topics are Radiotherapy, Adjuvant. Dr. Cheney's most frequent co-authors are Tracy A. Balboni, MD, MPH, Jennifer R. Bellon, MD and Edwin Choy, MD, PhD.

Dmand AI links Dr. Cheney to 10 clinical trials, 6 of them phase 3 studies. 9 are still active or recruiting. Conditions studied include Anal Canal Carcinoma, Lung Neoplasms and Oropharyngeal Neoplasms. NRG Oncology sponsors the most, 4.

CMS Open Payments shows 14 general payments to Dr. Cheney from 7 drug and device companies from 2016 to 2020. Food and beverage make up the largest share, 100% of the total. Celgene Corporation paid the most, $65.